These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6128546

  • 1. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
    Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA.
    Lancet; 1982 Dec 04; 2(8310):1237-40. PubMed ID: 6128546
    [Abstract] [Full Text] [Related]

  • 2. Lack of effect of captopril on the sodium retention of the nephrotic syndrome.
    Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA.
    Nephron; 1984 Dec 04; 37(1):43-8. PubMed ID: 6371561
    [Abstract] [Full Text] [Related]

  • 3. Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome?
    Brown EA, Markandu ND, Roulston JE, Jones BE, Squires M, MacGregor GA.
    Nephron; 1982 Dec 04; 32(2):102-7. PubMed ID: 6757778
    [Abstract] [Full Text] [Related]

  • 4. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome.
    Koomans HA, Geers AB, vd Meiracker AH, Roos JC, Boer P, Dorhout Mees EJ.
    Am J Nephrol; 1984 Dec 04; 4(4):227-34. PubMed ID: 6383042
    [Abstract] [Full Text] [Related]

  • 5. Considerations on the sodium retention in nephrotic syndrome.
    Usberti M, Gazzotti RM, Poiesi C, D'Avanzo L, Ghielmi S.
    Am J Nephrol; 1995 Dec 04; 15(1):38-47. PubMed ID: 7872363
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
    Pedraza-Chaverrí J, Cruz C, Chávez MT, Ibarra-Rubio ME, Tapia E, Peña JC.
    Rev Invest Clin; 1990 Dec 04; 42(3):210-6. PubMed ID: 2270368
    [Abstract] [Full Text] [Related]

  • 7. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA, Markandu N, Sagnella GA, Jones BE, MacGregor GA.
    Nephron; 1985 Dec 04; 39(4):290-5. PubMed ID: 3982574
    [Abstract] [Full Text] [Related]

  • 8. The pathophysiology of edema formation in the nephrotic syndrome.
    Siddall EC, Radhakrishnan J.
    Kidney Int; 2012 Sep 04; 82(6):635-42. PubMed ID: 22718186
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC.
    Rev Invest Clin; 1990 Sep 04; 42(1):29-38. PubMed ID: 2236972
    [Abstract] [Full Text] [Related]

  • 10. [The role of the renin-angiotensin system in the pathogenesis of nephrotic syndrome].
    Kutyrina IM, Klepikov PV, Tareeva IE.
    Ter Arkh; 1988 Sep 04; 60(6):32-4. PubMed ID: 3061050
    [Abstract] [Full Text] [Related]

  • 11. Role of sodium during formation of edema in children with nephrotic syndrome.
    Gurgoze MK, Gunduz Z, Poyrazoglu MH, Dursun I, Uzum K, Dusunsel R.
    Pediatr Int; 2011 Feb 04; 53(1):50-6. PubMed ID: 20573038
    [Abstract] [Full Text] [Related]

  • 12. Renal sodium retention in the nephrotic syndrome.
    Firth JD, Ledingham JG.
    Aust N Z J Med; 1991 Dec 04; 21(6):893-901. PubMed ID: 1818554
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin-aldosterone system in nephrotic syndrome.
    Hammond TG, Whitworth JA, Saines D, Thatcher R, Andrews J, Kincaid-Smith P.
    Am J Kidney Dis; 1984 Jul 04; 4(1):18-23. PubMed ID: 6377881
    [Abstract] [Full Text] [Related]

  • 14. A study of the renin-angiotensin system and the blood volume in the nephrotic syndrome.
    Yoo HD, Choi KS, Jung MH, Lee WS, Lee JW, Lee SR, Kim JS, Cho WK.
    Korean J Intern Med; 1986 Jan 04; 1(1):72-7. PubMed ID: 15759380
    [Abstract] [Full Text] [Related]

  • 15. Effect of the angiotensin converting enzyme inhibitor, captopril (SQ14,225), on orthostatic sodium and water retention in patients with idiopathic edema.
    Suzuki H, Fujimaki M, Nakane H, Saito I, Takeshita E, Saruta T.
    Nephron; 1985 Jan 04; 39(3):244-9. PubMed ID: 2983253
    [Abstract] [Full Text] [Related]

  • 16. Renal handling of sodium in the nephrotic syndrome.
    Perico N, Remuzzi G.
    Am J Nephrol; 1993 Jan 04; 13(5):413-21. PubMed ID: 8116693
    [Abstract] [Full Text] [Related]

  • 17. Thirst and sodium appetite in rats with experimental nephrotic syndrome.
    Xu J, Johnson AK, Thunhorst RL.
    Physiol Behav; 2015 Oct 01; 149():317-23. PubMed ID: 26120029
    [Abstract] [Full Text] [Related]

  • 18. Iso-oncotic volume expansion in the nephrotic syndrome.
    Rabelink TJ, Bijlsma JA, Koomans HA.
    Clin Sci (Lond); 1993 Jun 01; 84(6):627-32. PubMed ID: 8334809
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of sodium and water retention in edematous disorders.
    Paller MS, Schrier RW.
    Am J Kidney Dis; 1982 Sep 01; 2(2):241-54. PubMed ID: 6751072
    [Abstract] [Full Text] [Related]

  • 20. Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.
    Ray EC, Rondon-Berrios H, Boyd CR, Kleyman TR.
    Adv Chronic Kidney Dis; 2015 May 01; 22(3):179-84. PubMed ID: 25908466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.